Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 9408

Burbank, CA 91505

Study Summary:

The purpose of this study is to evaluate the safety and tolerability of 3 infusions of KD-247 over 2 weeks in HIV-1 seropositive individuals; to determine the pharmacokinetic parameters of KD-247 when administered as above; and to assess the effect of KD-247 infusions on plasma HIV-1 ribonucleic acid (RNA) load and on CD4+ T cell counts.

Qualified Participants Must:

• Be 18-64 years of age
• Have HIV viral load between 1000 and 100,000 copies/mL
• Have CD4 cell count of >350 cells/mm
• Be treatment naive, or off antiretroviral drugs for at least 8 weeks prior to screening
• Have a viral genotype sequence that conforms with the principal neutralizing determinant of KD-247 (will be determined by genotype testing)

Qualified Participants May Receive:

Physical Exam, all lab and blood work, ECG, possible financial compensation for time and travel up to $100 a visit.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.